Serum Institute of India (SII) is confident of getting approval for Covishield from European Medicines Agency (EMA) within a month.…
Pune: The Serum Institute of India (SII) announced on Friday that his company has manufactured the first batch of the…
New Delhi: Serum Institute of India (SII) is expected to begin clinical trials of Novavax’s COVID-19 vaccine ‘Covovax’ for children…
New Delhi: Covishield-maker Serum Institute of India (SII) has sought indemnity from liability or legal protection from any claims linked…
New Delhi: Executive Director of Pune-based Serum Institute of India (SII) Suresh Jadhav on Friday alleged that the government began…
New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said vaccines were never exported at the cost…
Pune: The Serum Institute of India (SII) on Saturday said that only a limited portion of its volume of Covidshield…
New Delhi: COVID-19 vaccine manufacturers Bharat Biotech and Serum Institute of India (SII) will get Rs 1,500 crore and Rs…
Pune: The Serum Institute of India (SII) has fully refunded South Africa for the 500,000 doses of the COVID-19 vaccine,…
New Delhi: The Serum Institute of India (SII) has geared up to raise the output of Covishield vaccines by 67%…